1[1]Randrianjafisamindrakotroka NS,Gasser B,Philippe E.The malignant potential of adenofibroma and cystadenofibroma of the ovary and mesovarium.118 cases including 13 proliferative and 5 carcinomatous.J Gynecol Obstet Biol Reprod(Paris),1993,22:33-38.
2[3]Bell DA,Scully RE.Benign and borderline clear cell adenofibromas of the ovary.Cancer,1985,56:2922-2931.
1Hart WR. Pathology of malignant and borderline (low malignant potential) epithelial tumors of ovary. In: Coppleson M, ed. Gynecologic oncology fundamental principles and clinical practice. New York: Churchill Livingstone, 1992. 863-887.
2Thingpen JT, Blessing JA, Ball H, et al. Phase Ⅱ trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study. J Clin Oncol, 1994, 12: 1748-1753.
3Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistant to platinum-based chemotherapy. Cancer, 2000, 88: 2584-2589.
4Kita T, Kikuchi Y, Kudoh K, et al. Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary. Oncol Rep, 2000, 7: 327-331.
5Behbakht K, Randall TC, Benjamin I, et al. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol, 1998, 70: 255-258.
6Jenison EL, Montag AG, Griffiths CT, et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol, 1989, 32: 65-71.
7Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage Ⅲ disease. Gynecol Oncol, 1996, 60: 412-417.
8Gorai I, Nakazawa T, Miyagi E, et al. Establishment and charac- terization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gynecol Oncol, 1995, 57: 33-46.
9Shimizu Y, Umezawa S, Hasumi K. A phase Ⅱ study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma. Ann Acad Med Singapore, 1998, 27: 650-656.
10Okubo T, Takeda S, Ikeba K, et al. Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary. Gan To Kagaku Ryoho, 1997, 24: 1279-1283.
1Sugiyama T, Nishida T, Kataoka A, et al. A pregnant woman with clear cell adenoccarcinoma of the ovary arising from endometriosis and with benign and borderline adenofibroma of the clear cell and endometrioid types[ J]. Eur Obste Gynecol Reprod Biol, 1997,72 (1) :47 -50.
2Akihisa S,Tanri S, Atsushi M, et al. Cystic clear cell tumor of borderline malignancy of the ovary lacking fibmmatous components : report of two cases and a possible new histol subtype [J]. Gynecologic Oncol,2006, 101(3) : 540 -544.
3Robboy SJ, Anderson MC, Russell P. Pathology of the femalereproductivetract[M].回允中主译.北京:北京大学医学出版社.2005.582-587.
